California Institute for Regenerative Medicine

Gladstone CIRM Scholars Program

The Gladstone CIRM Scholars Program, made possible with generous support from the California Institute for Regenerative Medicine (CIRM), is one of the hallmarks of Gladstone's stem cell research efforts. The program trains 10 biomedical scientists each year: seven postdoctoral and three clinical scholars.

Gladstone offers a unique training environment for CIRM Scholars, characterized by a commitment to educating the next generation of biomedical scientists—with substantial feedback from experienced mentors. Mentoring is a key aspect of the Gladstone postdoctoral program. This emphasis results from the commitment of an exemplary group of investigators who are dedicated to training young scientists.

The primary goal of the CIRM Scholars Program is to conduct research on regenerative medicine to develop new therapies for the treatment of disease.

Current CIRM Scholars

Conklin Laboratory
Nathaniel Huebsch, PhD
Luke Judge, MD, PhD

Ding Laboratory
Saiyong Zhu, PhD

Finkbeiner Laboratory
Kelly Haston, PhD
Julia Kaye, PhD

Huang Laboratory
Helen Fong, PhD

Srivastava Laboratory
Kimberly Cordes, PhD

Yamanaka Laboratory
Katie Worringer, PhD

Past CIRM Scholars

Yen Bui, MD, PhD
Irfan Kathiriya, MD, PhD
Yaisa Andrews-Zwilling, PhD
Shiro Baba, PhD
Cheng-Zhong Wang, PhD
Patrick Devine, PhD
Li Qian, PhD
Tim Rand, PhD
Kiichiro Tomoda, PhD
Silke Wissing, PhD
Zhiyuan Yang, PhD
Juan Jose Fung, PhD

CIRM Grants

Gladstone investigators have received several CIRM grants to advance their regenerative medicine programs. Gladstone has received $34.7 million in grants—more than many large academic institutions and a testament to the high quality of stem cell research being performed at Gladstone.

Current CIRM Grants

Benoit Bruneau, PhD
Induction of Cardiogenesis in Pluripotent Cells via Chromatin Remodeling Factors

Sheng Ding, PhD
Reprogramming of Human Somatic Cells back to Pluripotent Embryonic Stem Cells Autologous Retinal Pigmented Epithelial Cells Derived from Induced Pluripotent Stem Cells for the Treatment of Atrophic Age Related Macular Degeneration

Warner C. Greene, MD, PhD
Maximizing the Safety of Induced Pluripotent Stem Cells as an Infusion Therapy: Limiting the Mutagenic Threat of Retroelement Retrotransportation during iPSC Generation, Expansion, and Differentiation.

Yadong Huang, MD, PhD
Defining the Isoform-Specific Effects of Apolipoprotein E on the Development of iPS Cells into Functional Neurons in Vitro and in Vivo.

Robert Mahley, MD, PhD
Bruce Conklin, MD
CIRM Training Program

Deepak Srivastava, MD
Mechanisms of Direct Cardiac Reprogramming
The Gladstone CIRM Shared Human Embryonic Stem Cell Core Laboratory